REGEN-COV® for Treatment of Hospitalized Patients with Covid-19
Selin Somersan-Karakaya, Eleftherios Mylonakis, Vidya P. Menon, Jason C. Wells, Shazia Ali, Sumathi Sivapalasingam, Yiping Sun, Rafia Bhore, Jingning Mei, Jutta Miller, Lisa Cupelli, Andrea T. Hooper, Jennifer D. Hamilton, Cynthia Pan, Viet Pham, Yuming Zhao, Romana Hosain, Adnan Mahmood, John D. Davis, Kenneth C. Turner, Yunji Kim, Amanda Cook, Bari Kowal, Yuhwen Soo, A. Thomas DiCioccio, Gregory P. Geba, Neil Stahl, Leah Lipsich, Ned Braunstein, Gary A. Herman, George D. Yancopoulos, David M. Weinreich, for the Covid-19 Phase 2/3 Hospitalized Trial Team
doi: https://doi.org/10.1101/2021.11.05.21265656
Selin Somersan-Karakaya
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
M.D.Eleftherios Mylonakis
2Brown University, Providence, RI
M.D., Ph.D.Vidya P. Menon
3NYC Health + Hospitals/Lincoln, Bronx, NY
M.D.Jason C. Wells
4The Oregon Clinic, Portland, OR
M.D.Shazia Ali
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
Pharm.D.Sumathi Sivapalasingam
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
M.D.Yiping Sun
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
Ph.D.Rafia Bhore
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
Ph.D.Jingning Mei
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
Ph.D.Jutta Miller
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
B.S., R.N.Lisa Cupelli
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
Ph.D.Andrea T. Hooper
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
Ph.D.Jennifer D. Hamilton
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
Ph.D.Cynthia Pan
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
B.Pharm.Viet Pham
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
B.S.Yuming Zhao
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
M.S.Romana Hosain
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
M.D., M.P.H.Adnan Mahmood
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
M.D.John D. Davis
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
Ph.D.Kenneth C. Turner
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
Ph.D.Yunji Kim
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
Pharm.D.Amanda Cook
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
B.S., Dip.Reg.AffBari Kowal
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
M.S.Yuhwen Soo
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
Ph.D.A. Thomas DiCioccio
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
Ph.D.Gregory P. Geba
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
M.D., Dr.PH.Neil Stahl
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
Ph.D.Leah Lipsich
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
Ph.D.Ned Braunstein
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
M.D.Gary A. Herman
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
M.D.George D. Yancopoulos
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
M.D., Ph.D.David M. Weinreich
1Regeneron Pharmaceuticals, Inc., Tarrytown, NY
M.D.Article usage
Posted November 19, 2021.
REGEN-COV® for Treatment of Hospitalized Patients with Covid-19
Selin Somersan-Karakaya, Eleftherios Mylonakis, Vidya P. Menon, Jason C. Wells, Shazia Ali, Sumathi Sivapalasingam, Yiping Sun, Rafia Bhore, Jingning Mei, Jutta Miller, Lisa Cupelli, Andrea T. Hooper, Jennifer D. Hamilton, Cynthia Pan, Viet Pham, Yuming Zhao, Romana Hosain, Adnan Mahmood, John D. Davis, Kenneth C. Turner, Yunji Kim, Amanda Cook, Bari Kowal, Yuhwen Soo, A. Thomas DiCioccio, Gregory P. Geba, Neil Stahl, Leah Lipsich, Ned Braunstein, Gary A. Herman, George D. Yancopoulos, David M. Weinreich, for the Covid-19 Phase 2/3 Hospitalized Trial Team
medRxiv 2021.11.05.21265656; doi: https://doi.org/10.1101/2021.11.05.21265656
REGEN-COV® for Treatment of Hospitalized Patients with Covid-19
Selin Somersan-Karakaya, Eleftherios Mylonakis, Vidya P. Menon, Jason C. Wells, Shazia Ali, Sumathi Sivapalasingam, Yiping Sun, Rafia Bhore, Jingning Mei, Jutta Miller, Lisa Cupelli, Andrea T. Hooper, Jennifer D. Hamilton, Cynthia Pan, Viet Pham, Yuming Zhao, Romana Hosain, Adnan Mahmood, John D. Davis, Kenneth C. Turner, Yunji Kim, Amanda Cook, Bari Kowal, Yuhwen Soo, A. Thomas DiCioccio, Gregory P. Geba, Neil Stahl, Leah Lipsich, Ned Braunstein, Gary A. Herman, George D. Yancopoulos, David M. Weinreich, for the Covid-19 Phase 2/3 Hospitalized Trial Team
medRxiv 2021.11.05.21265656; doi: https://doi.org/10.1101/2021.11.05.21265656
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (697)
- Anesthesia (187)
- Cardiovascular Medicine (2822)
- Dermatology (242)
- Emergency Medicine (426)
- Epidemiology (12516)
- Forensic Medicine (10)
- Gastroenterology (798)
- Genetic and Genomic Medicine (4395)
- Geriatric Medicine (399)
- Health Economics (711)
- Health Informatics (2829)
- Health Policy (1043)
- Hematology (372)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4151)
- Nursing (220)
- Nutrition (614)
- Oncology (2186)
- Ophthalmology (622)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (263)
- Palliative Medicine (81)
- Pathology (483)
- Pediatrics (1166)
- Primary Care Research (481)
- Public and Global Health (6733)
- Radiology and Imaging (1480)
- Respiratory Medicine (895)
- Rheumatology (429)
- Sports Medicine (361)
- Surgery (469)
- Toxicology (57)
- Transplantation (198)
- Urology (173)